CREO MEDICAL LIMITED
Get an alert when CREO MEDICAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£743k
-76.4% lowest in 3 filed years
Net assets
-£188m
-16.6% lowest in 3 filed years
Employees
90
-35.3% lowest in 3 filed years
Profit before tax
-£27m
+20.9% highest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
Accordingly, the Directors concurred with management's conclusion that, while it remains appropriate to prepare the financial statements on a going concern basis, a material uncertainty exists related to the Company's dependence on continued parental support and the Group's ability to secure sufficient funding, which may cast significant doubt on the Company's ability to continue as a going concern.
-
Going-concern uncertainty disclosed
-
Negative shareholders' funds
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £3,005,000 | £1,479,000 | £4,023,000 | +172% | |
| Operating profit | -£25,142,000 | -£30,520,000 | -£21,046,000 | +31% | |
| Profit before tax | -£28,512,000 | -£34,311,000 | -£27,138,000 | +20.9% | |
| Net profit | -£25,810,000 | -£32,311,000 | -£27,138,000 | +16% | |
| Cash | £1,573,000 | £3,151,000 | £743,000 | -76.4% | |
| Total assets less current liabilities | — | — | — | — | |
| Net assets | -£129,627,000 | -£161,453,000 | -£188,238,000 | -16.6% | |
| Equity | — | — | — | — | |
| Average employees | 151 | 139 | 90 | -35.3% | |
| Wages | £9,168,000 | £8,561,000 | £6,170,000 | -27.9% | |
| Directors' remuneration | £400,000 | £90,000 | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Gearing (liabilities / total assets) | 729.3% | 954.6% | 1279.4% | |
| Current ratio | 4.87x | 6.24x | 3.51x | |
| Interest cover | -6.58x | -6.35x | -3.15x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- CREO MEDICAL LIMITED 2010-08-10 → present
- MICROONCOLOGY LTD 2003-02-06 → 2010-08-10
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“Accordingly, the Directors concurred with management's conclusion that, while it remains appropriate to prepare the financial statements on a going concern basis, a material uncertainty exists related to the Company's dependence on continued parental support and the Group's ability to secure sufficient funding, which may cast significant doubt on the Company's ability to continue as a going concern.”
Group structure
- CREO MEDICAL LIMITED · parent
- Creo Medical, Inc. 100%
- Creo Medical Innovations Limited 100%
- Creo Medical PTE Limited 100%
Significant events
- “Subsequent to the reporting date, Creo Medical Limited vacated its R&D facility in Bath and exited the associated lease arrangement. The Company expects to incur costs in respect of dilapidations and restoration obligations, which have been provided for at the reporting date based on management's best estimate.”
- “Subsequent to the reporting date, Creo Medical Ltd completed the disposal of its manufacturing operations to the existing management team through a management buyout (the "Manufacturing Disposal") for an undisclosed consideration. Under the terms of the Manufacturing Disposal, a newly established company controlled by the current management of Creo's manufacturing operations ("NewCo"), will, subject to the satisfaction of certain conditions, acquire all of Creo's UK manufacturing operations. As a result, 25 full-time employees will transfer from Creo to NewCo at closing. The transaction closed on 31st May 2026.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 14 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CRAVEN, Richard Gary | Secretary | 2024-07-01 | — | — |
| GULLIFORD, Craig Jonathan | Director | 2012-03-30 | May 1970 | British |
| HANCOCK, Christopher Paul, Prof | Director | 2003-02-20 | Mar 1967 | British |
| REES, Richard John | Director | 2016-07-01 | May 1976 | Welsh |
Show 14 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FROST, Kate | Secretary | 2014-08-12 | 2016-07-01 |
| HANCOCK, Christopher Paul, Dr | Secretary | 2003-02-20 | 2007-03-06 |
| REES, Richard | Secretary | 2016-07-01 | 2024-07-01 |
| SWIFT, Derek Alan | Secretary | 2007-03-06 | 2014-08-12 |
| DUPORT SECRETARY LIMITED | Corporate Nominee Secretary | 2003-02-06 | 2003-02-07 |
| CARTMELL, Simon Christopher | Director | 2014-10-23 | 2016-12-09 |
| CHAUDHRY, Mohammed Sabih, Doctor | Director | 2003-02-20 | 2007-03-06 |
| FARMER, Mark | Director | 2014-10-23 | 2016-12-09 |
| HALES, Philip William, Dr | Director | 2008-11-01 | 2010-02-08 |
| JACKSON, Mark Bentley | Director | 2009-07-22 | 2016-12-09 |
| MORRIS, Steven | Director | 2009-01-05 | 2019-02-25 |
| SPICER, Charles Alexander Evan, Dr | Director | 2016-07-01 | 2017-08-25 |
| WOODS, David Gerard | Director | 2015-09-10 | 2017-08-25 |
| DUPORT DIRECTOR LIMITED | Corporate Director | 2003-02-06 | 2003-02-07 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Creo Medical Group Plc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-12-09 | Active |
| Mr Richard John Rees | Individual | Significant influence, Significant influence (as firm) | 2016-07-01 | Ceased 2016-11-09 |
| Mr Craig Jonathan Gulliford | Individual | Significant influence, Significant influence (as firm) | 2016-04-06 | Ceased 2016-11-09 |
| Dr Christopher Paul Hancock | Individual | Significant influence, Significant influence (as firm) | 2016-04-06 | Ceased 2016-11-09 |
| Mr Steven Morris | Individual | Significant influence, Significant influence (as firm) | 2016-04-06 | Ceased 2016-11-09 |
Filing timeline
Last 20 of 147 total filings
Material constitutional events — rename, articles re-file, resolution
- 2021-11-02 MA Memorandum articles
- 2021-11-02 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-07-07 | AA | accounts | Accounts with accounts type full | |
| 2026-05-27 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2026-05-22 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-10-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-21 | AA | accounts | Accounts with accounts type full | |
| 2024-11-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-02 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-07-02 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-06-24 | AA | accounts | Accounts with accounts type full | |
| 2023-11-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-05 | AA | accounts | Accounts with accounts type full | |
| 2023-04-19 | AD02 | address | Change sail address company with old address new address | |
| 2022-11-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-06-21 | AA | accounts | Accounts with accounts type full | |
| 2021-11-24 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-11-24 | AD03 | address | Move registers to sail company with new address | |
| 2021-11-24 | AD02 | address | Change sail address company with new address | |
| 2021-11-02 | SH08 | capital | Capital name of class of shares | |
| 2021-11-02 | MA | incorporation | Memorandum articles | |
| 2021-11-02 | RESOLUTIONS | resolution | Resolution |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.